biopharmaceuticals
See the following -
Reinventing Investment: The Funding Landscape Of Life Science Shifts For Good
The legal landscape and requirements for a life sciences company to fundraise in the US are a nightmare, to put it gently. Guidelines changed recently with the Jumpstart Our Business Startups (JOBS) Act, and the sheer number of investment strategies for a life science startup executive to understand and pursue are staggering.
- Login to post comments
Using Scientific Publications Strategy to Ensure a Pharmaceutical Company's Credibility and a Product's Viability
Scientific publications remain the principal way that biopharmaceutical organizations relay critical clinical trial data to key external stakeholders such as physicians and payers. Data from different phases of drug development are the earliest ways these stakeholders learn about new products and the information serves as the building blocks for how a new product will be positioned in the marketplace...
- Login to post comments